Related Experiment Videos
[Study on mitoxantrone albumin microspheres for liver targeting]
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|January 1, 1997
Summary
Mitoxantrone albumin microspheres (DHAQ-BSA-MS) demonstrate excellent liver targeting and stability. These microspheres show potential for enhancing anti-hepatoma effects while reducing mitoxantrone toxicity.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Pharmacology
Context:
- Mitoxantrone is a chemotherapy drug with significant toxicity.
- Developing targeted drug delivery systems can improve efficacy and reduce side effects.
- Albumin microspheres offer a biocompatible platform for drug encapsulation.
Purpose:
- To establish an optimal procedure for preparing mitoxantrone albumin microspheres (DHAQ-BSA-MS).
- To characterize the physical, chemical, and in vivo properties of DHAQ-BSA-MS.
- To evaluate the liver-targeting potential and stability of the prepared microspheres.
Summary:
- Mitoxantrone albumin microspheres were successfully prepared using emulsion-heating solidification.
- Characterization revealed regular morphology, specific particle size distribution, and high drug loading efficiency (92.82%).
- In vivo studies in mice showed significant liver accumulation (77.6%) within 20 minutes post-injection, indicating remarkable liver targeting.
Impact:
- DHAQ-BSA-MS exhibit excellent stability and liver-targeting capabilities.
- This targeted delivery system holds promise for improving the anti-hepatoma effect of mitoxantrone.
- Potential to decrease the overall toxicity associated with mitoxantrone treatment.